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Clinics and pathology 
Disease 
Acute leukaemias; poorly known: only 3 available 
cases, and with different phenotypes: a T-cell ALL, a 
CD10+-ALL, and a 'CML-like' disease in 
transformation; all 3 were male patients. 
Genes involved and Proteins 
JAK2 
Location: 9p24 
DNA / RNA 
24 exons. 
Protein 




DNA / RNA 
9 exons; alternate splicing. 
Protein 
Contains a Helix-Loop-Helix and ETS DNA binding 
domains; wide expression; nuclear localisation; ETS-












5' ETV6 - 3' JAK2. 
Fusion protein 
Description 
N-term- HLH oligomerization domain from ETV6 
fused to the tyrosine kinase C-term domains of JAK2 
(or even starting with the JH2); the reciprocal JAK2-
ETV6 may not be expressed. 
Oncogenesis 
It may be speculated that the HLH domain of ETV6 
induces oligomerization, resulting in constitutive 
activation of the kinase domain of JAK2. 
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